Osiris Therapeutics, Inc. EBITDA Margin 2010-2018 | OSIR
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Osiris Therapeutics, Inc. (OSIR) over the last 10 years. The current EBITDA margin for Osiris Therapeutics, Inc. as of December 31, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-12-31 | $0.14B | $0.01B | 6.99% |
| 2018-09-30 | $0.14B | $0.00B | 2.96% |
| 2018-06-30 | $0.13B | 0 | 0.00% |
| 2018-03-31 | $0.12B | $-0.00B | -0.81% |
| 2017-12-31 | $0.12B | 0 | 0.00% |
| 2017-09-30 | $0.10B | $-0.04B | -38.54% |
| 2017-06-30 | $0.09B | $-0.04B | -39.56% |
| 2017-03-31 | $0.09B | $-0.04B | -40.70% |
| 2015-12-31 | $0.08B | $-0.03B | -40.00% |
| 2015-09-30 | $0.09B | $0.01B | 6.74% |
| 2015-06-30 | $0.08B | $0.01B | 7.41% |
| 2015-03-31 | $0.07B | $0.00B | 5.71% |
| 2014-12-31 | $0.06B | $0.00B | 3.39% |
| 2014-09-30 | $0.05B | $0.00B | 2.08% |
| 2014-06-30 | $0.04B | 0 | 0.00% |
| 2014-03-31 | $0.03B | $-0.00B | -3.33% |
| 2013-12-31 | $0.02B | $-0.00B | -8.33% |
| 2013-09-30 | $0.02B | $-0.00B | -5.26% |
| 2013-06-30 | $0.01B | $-0.00B | -14.29% |
| 2013-03-31 | $0.01B | $-0.01B | -45.45% |
| 2012-12-31 | $0.01B | $-0.01B | -62.50% |
| 2012-09-30 | $0.01B | $-0.03B | -450.00% |
| 2012-06-30 | $0.00B | $-0.02B | -550.00% |
| 2012-03-31 | $0.00B | $-0.02B | -800.00% |
| 2011-12-31 | $0.00B | $-0.01B | -1100.00% |
| 2011-09-30 | $0.00B | $0.01B | inf% |
| 2011-06-30 | $0.00B | $0.01B | inf% |
